Insight Molecular Earnings Estimate

IMDX Stock   5.82  0.41  7.58%   
The next projected EPS of Insight Molecular is estimated to be -0.24 with future projections ranging from a low of -0.24 to a high of -0.24. Insight Molecular's most recent 12-month trailing earnings per share (EPS TTM) is at -3.79. Please be aware that the consensus of earnings estimates for Insight Molecular Diagnostics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Insight Molecular is projected to generate -0.24 in earnings per share on the 31st of December 2026. Insight Molecular earnings estimates show analyst consensus about projected Insight Molecular Diagnostics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Insight Molecular's historical volatility. Many public companies, such as Insight Molecular, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Insight Molecular's earnings estimates, investors can diagnose different trends across Insight Molecular's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Insight Molecular's Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 0.41 in 2025, whereas Pretax Profit Margin is likely to drop (33.86) in 2025. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insight Molecular Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Insight Molecular Earnings Estimation Breakdown

The calculation of Insight Molecular's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Insight Molecular is estimated to be -0.24 with the future projection ranging from a low of -0.24 to a high of -0.24. Please be aware that this consensus of annual earnings estimates for Insight Molecular Diagnostics is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.3
-0.24
Lowest
Expected EPS
-0.24
-0.24
Highest

Insight Molecular Earnings Projection Consensus

Suppose the current estimates of Insight Molecular's value are higher than the current market price of the Insight Molecular stock. In this case, investors may conclude that Insight Molecular is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Insight Molecular's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2026Current EPS (TTM)
4-10.0%
-0.3
-0.24
-3.79

Insight Molecular Earnings per Share Projection vs Actual

Actual Earning per Share of Insight Molecular refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Insight Molecular Diagnostics predict the company's earnings will be in the future. The higher the earnings per share of Insight Molecular, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Insight Molecular Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Insight Molecular, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Insight Molecular should always be considered in relation to other companies to make a more educated investment decision.

Insight Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Insight Molecular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-08-11
2025-06-30-0.63-0.30.3352 
2025-05-12
2025-03-31-0.66-0.260.460 
2025-03-24
2024-12-31-1.12-1.93-0.8172 
2024-11-13
2024-09-30-0.4367-0.98-0.5433124 
2024-08-09
2024-06-30-0.37-0.432-0.06216 
2023-11-09
2023-09-30-1.01-0.810.219 
2023-08-10
2023-06-30-0.87-1.03-0.1618 
2023-05-11
2023-03-31-0.080.040.12150 
2023-03-31
2022-12-31-0.0938-0.4-0.3062326 
2022-11-10
2022-09-30-0.11-0.080.0327 
2022-08-10
2022-06-30-0.12-0.070.0541 
2022-05-11
2022-03-31-0.1214-0.110.0114
2022-03-10
2021-12-31-0.1229-0.39-0.2671217 
2021-11-09
2021-09-30-0.115-0.15-0.03530 
2021-08-10
2021-06-30-0.1006-0.12-0.019419 
2021-05-17
2021-03-31-0.0987-0.050.048749 
2021-03-16
2020-12-31-0.1075-0.090.017516 
2020-11-12
2020-09-30-0.0967-0.1-0.0033
2020-07-29
2020-06-30-0.1-0.14-0.0440 
2020-05-12
2020-03-31-0.11-0.13-0.0218 

About Insight Molecular Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Insight Molecular earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Insight Molecular estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Insight Molecular fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-350.5 M-333 M
Earnings Yield(1.95)(1.85)
Price Earnings Ratio(0.51)(0.54)
Price Earnings To Growth Ratio(0.02)(0.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.